Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Powell

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Gastroenterology & Hepatology|March 5, 2026
Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn's disease: a proof-of-concept studySulak Anandabaskaran, Zhigang Liu, Luke Hanna, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2020
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitisHajir Ibraheim, Samantha Baillie, Mark A Samaan, et al.
Blood|March 11, 2011
Monocytes control natural killer cell differentiation to effector phenotypesKatrina Soderquest, Nick Powell, Carmelo Luci, et al.
Frontiers in Immunology|April 28, 2023
CD90 is not constitutively expressed in functional innate lymphoid cellsJan-Hendrik Schroeder, Gordon Beattie, Jonathan W Lo, et al.
Gut|May 5, 2022
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severityCharlie W Lees, Tariq Ahmad, Christopher Andrew Lamb, et al.
Plos One|January 30, 2014
Automatic structural parcellation of mouse brain MRI using multi-atlas label fusionDa Ma, Manuel J Cardoso, Marc Modat, et al.
ESMO Open|July 10, 2020
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanomaDavid M Favara, Lavinia Spain, Lewis Au, et al.
Scientific Reports|August 19, 2025
Plasma interleukin-22 concentration and disease activity in inflammatory bowel diseaseClaudia Cabrera, Daniel Fernández-Llaneza, Marita Olsson, et al.
Frontiers in Immunology|February 19, 2021
T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid CellsJan-Hendrik Schroeder, Katrin Meissl, Dominika Hromadová, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2013
Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4M Refik Gökmen, Rong Dong, Aditi Kanhere, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Gastroenterology & Hepatology|March 5, 2026
Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn's disease: a proof-of-concept studySulak Anandabaskaran, Zhigang Liu, Luke Hanna, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2020
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitisHajir Ibraheim, Samantha Baillie, Mark A Samaan, et al.
Blood|March 11, 2011
Monocytes control natural killer cell differentiation to effector phenotypesKatrina Soderquest, Nick Powell, Carmelo Luci, et al.
Frontiers in Immunology|April 28, 2023
CD90 is not constitutively expressed in functional innate lymphoid cellsJan-Hendrik Schroeder, Gordon Beattie, Jonathan W Lo, et al.
Gut|May 5, 2022
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severityCharlie W Lees, Tariq Ahmad, Christopher Andrew Lamb, et al.
Plos One|January 30, 2014
Automatic structural parcellation of mouse brain MRI using multi-atlas label fusionDa Ma, Manuel J Cardoso, Marc Modat, et al.
ESMO Open|July 10, 2020
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanomaDavid M Favara, Lavinia Spain, Lewis Au, et al.
Scientific Reports|August 19, 2025
Plasma interleukin-22 concentration and disease activity in inflammatory bowel diseaseClaudia Cabrera, Daniel Fernández-Llaneza, Marita Olsson, et al.
Frontiers in Immunology|February 19, 2021
T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid CellsJan-Hendrik Schroeder, Katrin Meissl, Dominika Hromadová, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2013
Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4M Refik Gökmen, Rong Dong, Aditi Kanhere, et al.
Pageof 11